An Open-Label Study Evaluating the Bleeding Profile of Ortho Tri-Cyclen Lo (Norgestimate/Ethinyl Estradiol) Administered as an Extended Regimen

Trial Profile

An Open-Label Study Evaluating the Bleeding Profile of Ortho Tri-Cyclen Lo (Norgestimate/Ethinyl Estradiol) Administered as an Extended Regimen

Completed
Phase of Trial: Phase II

Latest Information Update: 14 May 2007

At a glance

  • Drugs Ethinylestradiol/norgestimate (Primary)
  • Indications Pregnancy
  • Focus Adverse reactions
  • Sponsors McNeil-PPC
  • Most Recent Events

    • 14 May 2007 New trial record.
    • 09 May 2007 Results have been published.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top